HomeFile

File

New Advances in Mitral Regurgitation Devices with Promising Results

Mitral regurgitation (MR) is a frequent valvulopathy and when the optimal medical treatment at maximum tolerated doses...

SAFE-TAVI Study: Safety and Efficacy of the Pressure Sensor and Pacing Guidewire

Currently, we observe an increase in the number of transcatheter aortic valve replacement (TAVR) procedures due to...

Heterotopic Tricuspid Intervention: TricValve One-Year Outcomes

Severe tricuspid regurgitation (TR) presents a reserved prognosis when not treated in time, seeing as systemic venous...

Predictors of Stroke at 30 Days and 6 Months After TAVR

While the rate of stroke has decreased since the early days of transcatheter aortic valve replacement (TAVR),...

iFR Guided PCI to the LAD: Same as for non-LAD Vessels?

iFR has been validated as a useful tool for intermediate lesion analysis, with the advantage of not...

Revascularization vs. Deferral of Physiologically Significant Lesions in the Left Main Coronary Artery

Most randomized studies on decision-making in coronary artery disease revascularization exclude left main coronary artery disease (LMCAD),...

Can Ultrasound Treat Aortic Stenosis?

Severe calcified aortic stenosis is a common condition that can currently be effectively treated with SAVR or...

Is AS Only Important When Severe?

Aortic stenosis (AS) is a progressive disease associated with morbidity and mortality, especially in severe cases. However,...